Clinical Trials Logo
  1. Home
  2. Eclampsia
  3. NCT02578810

PIERS and BIS, sFIT:PIGF, Adrenomedullin — BIS2  

Eclampsia Clinical Trial

Official title:
Sensitivity and Specificity of Bispectral Index (BIS) EEG Parameter, sFIT (Soluble FMS Tyrosine Kinase): PIGF (Placental Growth Factor) Ratio, Adrenomedullin for Grading Preeclampsia Integrated Estimate Risk Score (PIERS)

Clinical Trial Summary

Pre-eclampsia, more than being proteinuric gestational hypertension alone, is a state of exaggerated systemic inflammation and remains a leading direct cause of maternal morbidity and mortality worldwide.1 Standardization of antenatal and postnatal assessment and surveillance of pre-eclampsia with protocols that recognize the systemic inflammatory model of preeclampsia have been associated with reduced maternal morbidity.

Clinical Trial Description

Background: Pre-eclampsia, more than being proteinuric gestational hypertension alone, is a state of exaggerated systemic inflammation and remains a leading direct cause of maternal morbidity and mortality worldwide.1 Standardization of antenatal and postnatal assessment and surveillance of pre-eclampsia with protocols that recognize the systemic inflammatory model of preeclampsia have been associated with reduced maternal morbidity.2 To quantitatively asses electroencephalography (EEG) mental involvement in Pre-eclampsia is still time consuming and not always readily available. PIERS was developed and internally validate as a pre-eclampsia outcome prediction model- (Preeclampsia Integrated Estimate of RiSk) model.3 The purpose of our study was to evaluate the discriminative power of the Bispectral Index (BIS), biomarkers sFIT (soluble FMS-like Tyrosine Kinase): PIGF (Placental Growth Factor) ratio,4 and adrenomedullin mortality risk stratifier,5 to classify the degree and progression of pre-eclampsia. Methods: In 24 patients with Eclampsia or pre-eclampsia investigators will use an artefact-free 20-min mean BIS value, as well as biomarkers sFIT (soluble FMS-like Tyrosine Kinase): PIGF (Placental Growth Factor) ratio and adrenomedullin mortality risk stratifier to classify the degree of pre-eclampsia correlated the PIERS Pre-eclampsia risk assessment PIERS percentage (http://piers.cfri.ca/PIERSCalculatorH.aspx) will be calculated from patients' clinical and laboratory findings documented in their charts, compared with 24 pregnant patients without Eclampsia or pre-eclampsia. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02578810
Study type Observational
Source Suez Canal University
Contact Ashraf Dahaba, MD
Phone 00436509006761
Email ashraf.dahaba@medunigraz.at
Status Recruiting
Phase
Start date October 2016
Completion date December 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT02911701 - Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features Phase 4
Recruiting NCT06377878 - The Preeclampsia Registry
Recruiting NCT02020174 - The Preeclampsia Registry
Completed NCT05121415 - Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
Recruiting NCT02920593 - A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Phase 4
Completed NCT05143710 - The Clinical and Prognostic Features of PRES
Completed NCT03028194 - Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia N/A
Recruiting NCT05678062 - Point-of-care Ultrasound Abnormalities in Eclampsia N/A
Unknown status NCT02256995 - uChek Pilot Study for Urinalysis in the Antenatal Care Setting N/A
Completed NCT01751945 - Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project N/A
Recruiting NCT06069102 - Optimal Blood Pressure Treatment Thresholds Postpartum Phase 4
Recruiting NCT06219109 - Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
Completed NCT02765906 - Comparing Different Methods of Patient Education on Preeclampsia N/A
Completed NCT04160923 - Incidence and Neonatal Outcome of Eclamptic Parturient in Tertiary Hospital.
Recruiting NCT01856387 - The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia N/A
Recruiting NCT03200743 - Catestatin and Hypertension in Pregnancy N/A
Not yet recruiting NCT04855513 - Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial N/A
Completed NCT00000534 - Calcium for Pre-Eclampsia Prevention (CPEP) Phase 3
Recruiting NCT05655936 - Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial N/A
Not yet recruiting NCT06281665 - Treatment With Aspirin After Preeclampsia: TAP Trial Phase 4